BioSpace News Archive

Deals

Sangamo Therapeutics to Acquire TxCell

The Proposed Acquisition Would Combine Sangamo’s Ex Vivo Gene Editing Capabilities and TxCell’s Treg Expertise and Would Position Sangamo as a Leader in CAR-Treg Development

July 23, 2018
·
12 min read
Biotech Beach

No Toxicity Seen in Mice as Regen BioPharma, Inc. Finishes Initial Optimization of its Lead NR2F6 Small Molecule Agonist

Regen BioPharma Inc.'s lead candidate drug, RG-NAE005, was tested for its maximum tolerated dose in mice and showed no signs of toxicity.

July 23, 2018
·
2 min read
Perflow Medical Announces the First Clinical Use of the Cascade™ Dynamic Non-Occlusive Remodeling Net

And expands production capabilities through acquisition of TailorMed Ltd.

July 23, 2018
·
3 min read
Business

IAS 2018: Beckman Coulter Life Sciences Announces First Global CARES HIV/AIDS Award Winner

Recognizes ‘care, dedication and commitment’ of ordinary people

July 23, 2018
·
2 min read
Business

SanBio: Joint Research Agreement for SB623 Targeting Dementia

SanBio Company Limited announced it has concluded an agreement with Keio University School of Medicine on joint research for SB623 targeting dementia.

July 23, 2018
·
2 min read
OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System

OrthoSpin Ltd. announced that it completed an investment round of $3 million for its smart, robotic external fixation system for orthopedic treatments.

July 23, 2018
·
2 min read
BioForest

Telmediq Recognized in the Gartner Market Guide for Clinical Communication and Collaboration

Telmediq announced today that it has been listed as a Representative Vendor in Gartner’s 2018 Market Guide for Clinical Communication and Collaboration.

July 23, 2018
·
2 min read
Policy

Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-based Biopharmaceutical Development

Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia.

July 23, 2018
·
2 min read
Policy

CWCI Examines Prescription Drug UR/IMR Outcomes Under the California Workers’ Comp Formulary

A new California Workers’ Compensation Institute (CWCI) analysis offers a preliminary look at Utilization Review (UR) and Independent Medical Review (IMR) outcomes involving pharmaceutical requests for California injured workers since the state implemented a workers’ comp formulary in January of this year.

July 23, 2018
·
3 min read
Endomag Raises $10 Million USD (£8M GBP) to Establish a New Standard of Breast Cancer Care

Series C funding led by Draper Esprit

July 23, 2018
·
3 min read